-
effectivehealthcare.ahrq.gov/sites/default/files/calcineurin-inhibitor_disposition-comments.pdf
March 15, 2016 - The Symphony Trial
conclusion states The Symphony study showed that at
1 year post transplant a regimen … Based on a 25
year heritage as a pioneer in transplant
immunosuppression, we are sharing the following … Peer Reviewer 3 Introduction Page 3, Lines 27-28: the description of desensitization
regimens should … Peer Reviewer 3 Conclusion A strong and succinct description of the risks and
benefits of the various … We have revised the
Conclusion to include a more
useful description of the risks
and benefits of different
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-5-protocol-update-2023.pdf
January 01, 2023 - After studies are screened and determined to meet inclusion criteria, we will abstract study
design, year … Data Synthesis:
Characteristics of included studies, such as number of publications by year, study sample … Author
2. Year of publication
3. Bibliographic citation
4. PubMed ID
5. … Year of publication
2. Study class
3. Country/Countries of study sites
4. Site type
5. … Treatment Description
4.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer-update_disposition.pdf
December 09, 2014 - In addition, note that the
correct name of the author in ref 13
is Bucci not Burri. … A more detailed description
of this process would be helpful. … and
year in other instances. … We use the AHRQ convention for
citations and refer to author and date
when highlighting a specific … The SBRT description should be
much better.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-anxiety-children_0.pdf
October 01, 2018 - This report is made available to the public under the terms of a licensing agreement between the
author … ....................................................................... 2
Process Description .... … Results
Final Product Description
Health System Decision Aid
The final health system decision … and explicit description of the population, its comorbidities and characteristics. … o Information available in reports but require more synthesis or emphasis:
Explicit description of
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/version-2-risk-of-reinfection-from-SARSCoV2_0.pdf
December 31, 2022 - A complete description of the search strategy can be
found in Appendix A. … Joanna Briggs Institute cohort checklist used in study screening
Author, Year 1 2 3
4 5 6 7 … Risk of bias and overall study quality ratings
Author Sampling Risk
of Bias
Cohort Allocation … Uncontrolled studies of reinfection from SARS-CoV-2
Author Title Country Population
Graham, 202144 … This report is made available to the public under the terms of a licensing agreement between the author
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-social-isolation-older-adults-final.pdf
February 01, 2019 - Physical activity interventions
Author, Year
Study Design
Intervention
Duration
Country
Study Quality … C-2
Author, Year
Study Design
Intervention
Duration
Country
Study Quality
Population Intervention … C-3
Author, Year
Study Design
Intervention
Duration
Country
Study Quality
Population Intervention … Arts and recreation interventions
Author, Year
Study Design
Intervention
Duration
Country
Study … Health services access interventions
Author, Year
Study Design
Intervention
Duration
Country
Study
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-emergency_disposition-comments.pdf
November 27, 2012 - In the description of included studies section,
we added a statement that “in 43 (61%)
studies, migraine … In the description of included studies section,
we added a statement that “in 43 (61%)
studies, migraine … We added a statement in the description of
included studies section that stated, “in 44
studies, migraine … In the description of included studies section,
we added a statement that “in 43 (61%)
studies, migraine … We have added the following information in the
ES and main report (description of included
studies)
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/sleep-apnea_disposition-comments.pdf
October 25, 2011 - Our description of an association has been improved. … This
may be a problem with clarity of description
rather than the actual data. … We have expanded our description of
these concepts in the introduction and added the above text
to … Our clinical expert stands by
our description. … Increased
Incidence of Cardiovascular Disease in Middle-
aged Men with Obstructive Sleep Apnea: A 7-
Year
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-reporting-bias_methods.pdf
November 01, 2013 - of the project or fiscal year of funding. … When trying to contact a study
19
author, there is little guidance as to how many times this … reviewers conducted by Mullan, et al.84 reported that most
respondents contacted at least one study author … Trying to contact one study author three times and other
study authors once is systematically different … FDA Web Site – Drugs@FDA
Agency URL Description
U.S.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-cough_disposition-comments.pdf
January 07, 2013 - The
audience of this report is not explicitly stated but assumed based
on the general description of … Peer Reviewer #3 General Description of the studies suggests none was an RCT, but the
table includes … The revised “Description of Included
Studies” section for KQ2 states,
“Thirty-three of the 48 studies … The
report is generally very well-written and is exhaustive in the
description of the approach. … As suggested, we have modified our
description of the control group to
clarify.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/engaging-caregivers-rapid-review.pdf
April 01, 2024 - We organized information according to the review questions, and noted the author,
year, study design … Details of studies focused on hospital discharge care transitions
Author, Year
Risk of Bias
Study … Details of studies focused on transfers from intensive care units
Author, Year
Risk of Bias … Details of studies focused on other care transitions
Author, Year
Risk of Bias
Study Design … Patient safety practice implementation facilitators and barriers
Author, Year Implementation Facilitators
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-diagnosis_disposition-comments.pdf
June 12, 2012 - The detailed
description of the search strategies and key terms would allow for
replication. … Safety of contrast agent use during stress
echocardiography: a 4-year experience from a
single-center … Safety of contrast agent
use during stress echocardiography: a 4-year experience from a single-
center … statement is incorrect given that there are about 1-2 million
diagnostic angiograms performed each year … The methodology section has no description of the method used.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/dietary-protein-intake-disposition-comments.pdf
November 22, 2024 - ● We made several word edits suggested by peer reviewers including refinement of the
description … products/dietary-protein-intake/research
Published Online: November 22, 2024
2
Public Comments and Author
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/vte-prophyalaxis_disposition-comments.pdf
May 29, 2013 - We share some of the reviewers concern
regarding the description of filter related
thrombosis. … Despite these concerns we
believe that such outcomes should be
included with a nuanced description … - not to the
best of my knowledge
Thanks
Reviewer 10 Results What was the span of publication year … patients (one is trauma and 1 is ortho trauma, but both are
same years, same institition, same first author … propensity matched analysis
which was one of the top ten studies presented at the ASMBS meeting this year
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/study-design-classification_research.pdf
December 01, 2010 - The findings and conclusions in this document are
those of the author(s), who are responsible for its … Description of study design classification tools rejected for further evaluation................8
Table … Classification of studies: Round 1
Study
(author,
year)
Reference
Standard
NonR
trial RCT Prosp … Classification of studies: Round 1 (continued)
Study
(author,
year)
Reference
Standard
NonR … Classification of studies: Round 2
Study
(author,
year)
Reference
Standard
NonR
trial RCT Prosp
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-update_research-protocol.pdf
January 15, 2015 - effectiveness reviews, and will include elements that address
population characteristics including description … between the comparative
groups or overall high loss to follow-up, and the validity and adequacy of the description … descriptions of the study design, intervention(s), mean
baseline blood pressure and kidney function, description
-
effectivehealthcare.ahrq.gov/sites/default/files/palliative-care-tools-disposition.pdf
May 04, 2017 - Expand the description of each Domain here using the
source document. … The author
makes a conclusion there is no tool available for the legal
aspects. … The authors should consider contacting the
principle author to review their findings. … Not clear from
the description. … very
comprehensive review of patient experience tools that we
used for this review, that covered the year
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/palliative-care-tools-disposition.pdf
May 04, 2017 - Expand the description of each Domain here using the
source document. … The author
makes a conclusion there is no tool available for the legal
aspects. … The authors should consider contacting the
principle author to review their findings. … Not clear from
the description. … very
comprehensive review of patient experience tools that we
used for this review, that covered the year
-
effectivehealthcare.ahrq.gov/sites/default/files/tympanostomy-tubes-disposition.pdf
May 05, 2017 - Peer
Reviewer #1
Executive Summary P24
Also, the description of KQ
2 is much smaller and
does … I strongly object
to the current wording, and
as the first author of the
CPG can definitively state … The first description on pg. 59 refers to the full
matrix of treatment effects. … did not report any details beyond
"Hearing levels were normal in all children, in both
groups, at 1-year … Appendix tables have been regenerated, sorted
Alphabetically by author
TEP/KI
Reviewer # 1
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tympanostomy-tubes-disposition.pdf
May 05, 2017 - Peer
Reviewer #1
Executive Summary P24
Also, the description of KQ
2 is much smaller and
does … I strongly object
to the current wording, and
as the first author of the
CPG can definitively state … The first description on pg. 59 refers to the full
matrix of treatment effects. … did not report any details beyond
"Hearing levels were normal in all children, in both
groups, at 1-year … Appendix tables have been regenerated, sorted
Alphabetically by author
TEP/KI
Reviewer # 1